sclareol has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jovanović, NT; Kostić, A; Lupšić, E; Nedialkov, P; Novaković, M; Opsenica, IM; Pešić, M; Stojković, P; Trendafilova, A | 1 |
1 other study(ies) available for sclareol and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Collateral Sensitivity; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioblastoma; Humans; Pyrimidines | 2023 |